Abstract
The low survival and differentiation rates of transplanted stem cells are the main obstacles to stem cell therapy in traumatic brain injury (TBI). Stromal cell derived factor-1 (SDF-1)/CXCR4 are key factors that regulate the cell activity, homing and differentiation of stem cells. Herein, we synthesized sodium alginate (SA)/collagen type I (Col)/SDF-1 hydrogel and investigated whether SA/Col/SDF-1 could improve the efficacy of bone marrow-derived mesenchymal stem cells (BMSCs) in TBI model. Our results showed that SA/Col/SDF-1 scaffold could continuously and stably release SDF-1 and provide a biocompatible and biodegradable microenvironment for the survival, migration and neuronal differentiation of BMSCs in vitro. In a rat model of TBI, SA/Col/SDF-1 hydrogel loaded with BMSCs significantly ameliorated neurological deficits and relieved anxiety and depressive-like behaviors. In addition, BMSCs/SA/Col/SDF-1 scaffold could reduce brain lesion and neuronal cell death, as well as mitigate neuroinflammation. Further studies demonstrated that BMSCs/SA/Col/SDF-1 promoted the migration of BMSCs in the lesions and enhanced neurogenesis partly by activating the SDF-1/CXCR4-mediated FAK/PI3K/AKT pathway. Taken together, our results indicate that SA/Col/SDF-1 scaffold enhances the neuroprotective effects of BMSCs in TBI rat model, which may serve as an alternative neural regeneration strategy for brain injury repair.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have